21 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
.
Table of Contents
DEFINITIONS
LICENSE
GOVERNANCE
DEVELOPMENT AND REGULATORY MATTERS
COMMERCIALIZATION
MANUFACTURE AND SUPPLY
PAYMENTS
COMPLIANCE … other intellectual property of Licensor in connection with any Competitive Product.
3. GOVERNANCE
3.1. Joint Steering Committee
3.1.1. Establishment
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
23 Jun 23
House Lease Contract
4:31pm
research projects and funds;
(5)Management consulting services such as corporate structure and governance model;
(6)Market development support
20-F
EX-4.5
5hdclr8 qh
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.12
v5au9d4ubt7foawsb
31 Mar 22
Annual report (foreign)
4:33pm
20-F
uz71ofpsnz2gh
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-1.1
0eieyut9g jopfz6s
31 Mar 22
Annual report (foreign)
4:33pm
6-K
5k5zvplweb nbp1fem3k
27 Aug 21
Current report (foreign)
4:10pm
424B4
f1iro
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
s6mg 88zjax3q7q
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
aa2c e61r
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-3.2
e9qhc4qiymtmmkdnfg
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-4.4
ny8ap1qcyw0k
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
4vmlg46 x5ro
26 Feb 21
Registration statement (foreign)
4:56pm
DRSLTR
x0rm4
26 Jan 21
Correspondence regarding draft registration statement
12:00am
DRS/A
p4c2perqlnbc 2bxeqv
26 Jan 21
Draft registration statement (amended)
12:00am
UPLOAD
gikr2fp
13 Jan 21
Letter from SEC
12:00am
DRS
k3e6x6b5u00aqlifg
17 Dec 20
Draft registration statement
12:00am